“These new initiatives support the continued progress on our environmental commitments to be net zero and nature positive by 2030, which we’ll share more on COP26.” “We also announced the new R&D program to reduce greenhouse gas emissions from metered dose inhalers which are responsible for 45% of the Company’s carbon emissions,” the firm said on its Q3 call. The firm, which is one of the sponsors at COP26, announced a £50 million ($68 million) investment back in September aimed at reducing greenhouse gas emissions by installing wind turbines and solar panels at plants in Irvine, Scotland and Oak Hill, New York, which the company says accounts for almost half of its total carbon emissions.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |